Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon

Bulletin of the World Health Organization

Volumn 77, Issue 1, 1999, Pages 34-43

  Ringwald, P ^a,b   Basco, L K ^b  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

COMPARATIVE STUDY; DRUG RESISTANCE; HEALTH CARE;

ACCURACY; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CAMEROON; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TREATMENT OUTCOME; VALIDATION PROCESS;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CAMEROON; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE;

CAMEROON;

EID: 0033044194     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. International travel and health. Vaccination requirements and health advice. Geneva, World Health Organization, 1999.
2. Turaman C, Basco LK, Le Bras J. Evaluation of therapeutic efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by simplified in vivo test. Bulletin of the World Health Organization, 1992, 70: 477-480.
3. Adagu IS et al. Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 422-425.
4. Chandenier J et al. Chimiosensibilité in vivo et in vitro de Plasmodium falciparum à Brazzaville (Congo). Cahiers Santé, 1995, 5: 25-29.
5. Management of uncomplicated malaria and the use of antimalarial drugs for the protection of travellers. Geneva, World Health Organization, 1996 (unpublished document WHO/MAL/96.1075, available upon request from Division of Control of Tropical Diseases, World Health Organization, 1211 Geneva 27, Switzerland).
6. Bruce-Chwatt LJ et al. Chemotherapy of malaria, 2nd ed. Geneva, World Health Organization, 1984.
7. Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas with intense transmission. Geneva, World Health Organization, 1996 (unpublished document WHO/MAL/96.1077 available upon request from Division of Control of Tropical Diseases, World Health Organization, 1211 Geneva 27, Switzerland.
8. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group. Geneva, World Health Organization, 1973 (WHO Technical Report Series, No. 529).
9. Payne D, Wernsdorfer WH. Development of a blood culture medium and a standard in vitro microtest for field-testing the response of Plasmodium falciparum to antifolate antimalarials. Bulletin of the World Health Organization, 1989, 67: 59-64.
10. Desjardins RE et al. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial agents and chemotherapy, 1979, 16: 710-718.
11. 3H]hypoxanthine incorporation. Experimental parasitology, 1983, 55: 138-146.
12. Webster HK et al. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. American journal of tropical medicine and hygiene, 1985, 34: 228-235.
13. Childs GE, Wimonwattrawatee T, Pooyindee N. Evaluation of an in vitro assay system for drug susceptibility of field isolates of Plasmodium falciparum from southern Thailand. American journal of tropical medicine and hygiene, 1988, 38: 19-23.
14. Mount DL et al. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroguine and its metabolites in urine. Bulletin of the World Health Organization, 1989, 67: 295-300.
15. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990, 84: 1-65.
16. Rieckmann KH. Monitoring the response of malaria infections to treatment. Bulletin of the World Health Organization, 1990, 68: 759-760.
17. Ringwald P, Bickii J, Basco LK. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. American journal of tropical medicine and hygiene, 1996, 55: 254-258.
18. Ringwald P, Bickii J, Basco LK. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet, 1996, 347: 24-28.
19. Bickii J, Basco LK, Ringwald P. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. Journal of clinical microbiology, 1998, 36: 243-247.
20. Cohen J. A coefficient of agreement for nominal scales. Educational and psychological measures, 1960, 20: 27-46.
21. Fermanian J. Mesure de l'accord entre deux juges. Cas qualitatif. Revue épidémiologique et santé publique, 1984, 32: 140-147.
22. Schapira A et al. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: Correlation of in vivo and in vitro results. American journal of tropical medicine and hygiene, 1986, 35: 239-245.
23. Björkman A, Willcox M. In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, 80: 572-574.
24. Petersen E et al. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil. Annals of tropical medicine andparasitology, 1990, 84; 563-571.
25. Warsame M et al. Positive relationship between the response of Plasmodium falciparum to chioroquine and pyronaridine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85: 570-571.
26. Brasseur P et al. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. 1. Stable figures of prevalence of chloroquine-and quinine-resistant isolates in the original foci. American journal of tropical medicine and hygiene, 1992, 46: 1-7.
27. Basco LK, Le Bras J. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. American journal of tropical medicine and hygiene, 1993, 49: 301-307.
28. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta tropica, 1994, 56: 143-156.
29. Geary TG, Divo AA, Jensen JB. An in vitro assay system for the identification of potential antimalarial drugs. Journal of parasitology, 1983, 69: 577-583.
30. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science, 1976, 193: 673-675.
31. Le Bras J et al. Plasmodium falciparum: Drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Experimental parasitology, 1983, 56: 9-14.